Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This phase 0 trial studies hydroxychloroquine in blocking autophagy in patients with prostate cancer who are undergoing surgery or active surveillance. Autophagy is a process in which cells break down some parts of themselves to stay alive during times of stress, such as starvation. This may allow cancer cells to survive damage from chemotherapy. Hydroxychloroquine may block this process from happening.
Epistemonikos ID: 1e9452fe16fd2d9034f8b9156114e084d38b4764
First added on: May 12, 2024